HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Targher, G. Articles by Zoppini, G. Search for Related Content PubMed PubMed Citation Articles by Targher, G. Articles by Zoppini, G. Social Bookmarking                What's this?

Plasma Total Homocysteine Levels Are Associated With von Willebrand Factor, Soluble Intercellular Adhesion Molecule-1, and Soluble Tumor Necrosis Factor- Receptors in Young Type 1 Diabetic Patients Without Clinical Evidence of Macrovascular Complications

¹ Diabetes Unit, Sacro Cuore Hospital of Negrar, Negrar
² Division of Endocrinology and Metabolic Diseases, University of Verona Medical School, Verona, Italy

Elevated plasma total homocysteine (tHcy) levels are a powerful risk factor for atherosclerotic vascular disease (1), but it is still unclear by which pathophysiological mechanisms tHcy may promote atherothrombosis. In both experimental animal and cell culture studies (2,3), acute hyperhomocysteinemia induces endothelial dysfunction, leading to a low-grade inflammatory state that results in increased leukocyte adherence by upregulation of cell adhesion molecules. Accordingly, an impaired endothelium-dependent flow-mediated dilation was found in nondiabetic subjects with high tHcy when compared with subjects with low tHcy levels (4). In a recent cross-sectional study (5) of both nondiabetic individuals and type 2 diabetic subjects, tHcy was significantly associated with endothelial dysfunction, as estimated from plasma von Willebrand factor (vWF), and with leukocyte adhesion, as estimated from plasma vascular cell adhesion molecule-1. To our knowledge, there is a lack of available data regarding the relationships of tHcy levels with plasma markers of endothelial dysfunction . . . [Full Text of this Article]

FOOTNOTES

References

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]

				M. F. Lopes-Virella, R. E. Carter, G. E. Gilbert, R. L. Klein, M. Jaffa, A. J. Jenkins, T. J. Lyons, W. T. Garvey, G. Virella, and and the DCCT/EDIC Cohort Study Group Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications Diabetes Care, October 1, 2008; 31(10): 2006 - 2012. [Abstract] [Full Text] [PDF]

				J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults Diabetes Care, June 1, 2007; 30(6): 1549 - 1555. [Abstract] [Full Text] [PDF]

				A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults Diabetes Care, April 1, 2007; 30(4): 980 - 986. [Abstract] [Full Text] [PDF]

				A. G. Pittas, B. Dawson-Hughes, T. Li, R. M. Van Dam, W. C. Willett, J. E. Manson, and F. B. Hu Vitamin d and calcium intake in relation to type 2 diabetes in women. Diabetes Care, March 1, 2006; 29(3): 650 - 656. [Abstract] [Full Text] [PDF]

				M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher Serum 25-hydroxyvitamin d3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care, March 1, 2006; 29(3): 722 - 724. [Full Text] [PDF]

				S. Liu, Y. Song, E. S. Ford, J. E. Manson, J. E. Buring, and P. M. Ridker Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women Diabetes Care, December 1, 2005; 28(12): 2926 - 2932. [Abstract] [Full Text] [PDF]

				E. S. Ford, U. A. Ajani, L. C. McGuire, and S. Liu Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults Diabetes Care, May 1, 2005; 28(5): 1228 - 1230. [Full Text] [PDF]

				M. F Holick Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1678S - 1688S. [Abstract] [Full Text] [PDF]

				K. C Chiu, A. Chu, V. L. W Go, and M. F Saad Hypovitaminosis D is associated with insulin resistance and {beta} cell dysfunction Am. J. Clinical Nutrition, May 1, 2004; 79(5): 820 - 825. [Abstract] [Full Text] [PDF]

				E Svenungsson, G-Z Fei, K Jensen-Urstad, U de Faire, A Hamsten, and J Frostegard TNF-{alpha}: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease Lupus, June 1, 2003; 12(6): 454 - 461. [Abstract] [PDF]